GlassScriptPhysician profile
Galina M Vayner
NPI 1891786497
$2,914.06
in general payments reported to CMS, 2019-2025
33 companies · $272 in 2025
The $272 reported for 2025 was more than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $87.12 · 2020: $227 · 2021: $259 · 2022: $441 · 2023: $712 · 2024: $916 · 2025: $272.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,899.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,899.34 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Novo Nordisk INC | $833.51 | 2020-2025 | Rybelsus, Ozempic |
| Sumitomo Pharma America, INC. | $253.04 | 2023-2025 | Gemtesa |
| Abbvie INC. | $247.64 | 2019-2024 | Linzess, Viberzi, Synthroid |
| Ferring Pharmaceuticals INC. | $192.59 | 2019-2024 | Euflexxa |
| Abbott Laboratories | $185.07 | 2023-2024 | Mitraclip, Freestyle Libre 2, Freestyle Libre 3 |
| Glaxosmithkline, LLC. | $146.37 | 2022-2025 | Trelegy Ellipta, Arexvy |
| Exact Sciences Corporation | $101.48 | 2023-2025 | Cologuard Collection Kit |
| Astrazeneca Pharmaceuticals LP | $95.64 | 2022-2025 | Farxiga, Airsupra, Breztri |
| Corium, LLC | $93.00 | 2023 | Adlarity |
| Amgen INC. | $79.57 | 2020-2025 | Otezla, Repatha, Otezla |
| Amarin Pharma, INC. | $73.42 | 2020-2021 | |
| Pfizer INC. | $66.09 | 2022-2024 | |
| Xeris Pharmaceuticals, INC. | $63.55 | 2024-2025 | Gvoke Hypopen |
| Boehringer Ingelheim Pharmaceuticals, INC. | $47.32 | 2024 | Jardiance |
| Baxter Healthcare | $43.88 | 2023 |
Show all 33 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $43.71 | 2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $38.66 | 2019-2022 | |
| Daiichi Sankyo INC. | $34.45 | 2023 | Injectafer |
| Esperion Therapeutics, INC. | $32.35 | 2024 | Nexletol |
| Ardelyx, INC. | $27.46 | 2024 | Ibsrela |
| Teleflex LLC | $25.02 | 2024 | Urolift |
| Ironwood Pharmaceuticals, INC | $23.24 | 2024 | |
| Corcept Therapeutics | $21.52 | 2025 | Korlym |
| Allergan, INC. | $18.23 | 2020 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $17.50 | 2022 | |
| Biogen, INC. | $17.28 | 2020 | |
| Aimmune Therapeutics, INC. | $16.33 | 2025 | Zenpep |
| Phathom Pharmaceuticals, INC. | $14.33 | 2024 | Voquezna |
| Bayer Healthcare Pharmaceuticals INC. | $13.65 | 2024 | |
| Redhill Biopharma INC. | $13.19 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $12.10 | 2022 | |
| Dexcom, INC. | $11.69 | 2022 | |
| Astellas Pharma US INC | $11.18 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Galina Vayner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.